FemTech company focused on vaginal health

About Pharmiva

Pharmiva is a Swedish company active within FemTech that develops innovative and antibiotic-free treatments to improve vaginal health. The Company’s first product, Vernivia®, is a CE-approved, over-the-counter vaginal mousse for the treatment of bacterial vaginosis (BV); a common vaginal infection that affects 1 in 3 women between the ages of  14–49 years. Vernivia® vaginal mousse provides women with an effective treatment that cures the infection and provides a rapid symptom relief without problematic side-effects that are associated with current antibiotic treatments. The launch of Vernivia®, through Swedish pharmacies, marks the first step towards Pharmiva’s goal of becoming a global FemTech company, with a broad portfolio of antibiotic-free products for vaginal health. Together, the employees at Pharmiva have broad experience and knowledge from the life science sector, in the fields of therapeutics and product development. 

Pharmiva is listed on Nasdaq First North Growth Market, for more information visit  www.pharmiva.com

The partner Fondkommission AB is the Company’s Certified Adviser, (telephone +46 317 612 230) ,  www.partnerfk.se

References:
  1. 1177, Bacterial vaginosis, What can I do myself?

Carlsquare Equity Research sees positive signals for Pharmiva’s product Vernivia and publishes update of its initial analysis

To read the update from Carlsquare Equity Research, click here.

Management team

Per-Ola Forsberg, CFO

Per-Ola Forsberg

CFO since February 2020

General info: :
Per-Ola was born in 1961 and holds a degree in Business and Economics from Lund University, Sweden.

Experience:
Per-Ola has over 25 years of experience in the pharmaceutical and biotechnology industry, and previous assignments include roles as CFO at Idogen, LIDDS, Lund University Bioscience and Probi. At Probi, he acted as Vice President, over a period, and was responsible for the Company’s business operations. Previous positions include Controller at Rexam Beverage Can Fosie, Head of Administration at PolyPeptide Laboratories and Subsidiary of Ferring. Per-Ola has also contributed to three IPOs. His current role is as CFO at Pharmiva. 

.

Other ongoing assignments
Rapidsrock AB (own consulting company) 

Holings in Pharmiva AB: 
21 500 shares

Karoline Akerjordet, COO

Karoline Akerjordet

Acting CEO since May 2022

General info: :
Karoline was born in 1983 and holds a M. Sc. in Molecular Biology. 

Experience:
Karoline has more than 10 years of experience from the pharmaceutical industry, including 7 years at the pharmaceutical company Novo Nordisk, holding various management positions, followed by 4 years as Sales Manager at Particle Measuring System, a provider of technical equipment to pharmaceutical companies and hospitals. Prior to this, she worked as an analyst in a biochemical laboratory at a hospital in Denmark. 

Other ongoing assignments:
n/a

Holdings in Pharmiva AB: 
1 100 shares, 45 000 options  

Andrea Mildner

Sales & Marketing Director since February 2022

General info: :
Andrea was born in 1980 and holds a M.Sc. in Int. Marketing & Management from CBS/Denmark.

Experience:
UnderAndrea has spent the last decade developing effective marketing communications. At first, she acted as a consultant for brands like Tetra Pak, Trelleborg, Apoteket, Total Nordic, Carlsberg and Hilding Anders. From there on, her focus has been on e-commerce, digital marketing and development in FMCG and retail. As Digital Manager at Orkla Sweden’s marketing department, she was involved in creating a digital team, supporting brands with digital strategies, social channel content and initiatives to engage costumers through brand experience. Following, she was involved in change projects within Global Communication at Ingka Services, such as ingka.com, and the development of new services and tools to engage and communicate effectively to the many employees internally. 

Other ongoing assignments:

n/a

Holdings in Pharmiva AB: 

2200 shares

Board of Directors

Malte Zaunders, styrelsens ordförande

Malte Zaunders

Malte Zaunders Chairman since 2020, director since 2015

General info:
Malte was born in 1975 and holds a M.Sc. in Engineering from Chalmers University of Technology, Sweden and London Business School.

Experience:
Malte has been involved in Pharmiva since founding. He has more than 20 years of advisory and investment experience from JP Morgan and Zolfo Cooper (London, UK), among others. Currently, he is a Managing Partner at AZ Growth Capital and Hortus Group.

Other ongoing assignments
AZ Growth Capital AB (Chairman), Hortus Group AB (director), Link Group Europe AB (director), Crunchfish AB (director), Adrenaline Travel AB (director). 

Holdings in Pharmiva AB:
305 241 shares directly and 40 765 through endowment insurance 

Independent:
Not independent in relation to the Company, independent in relation to the owners .

David Sagna

David Sagna

Director since 2015

General info:
David was born in 1975 and holds a master’s degree in Analytical Chemistry. 

Experience:
David has more than 20 years of experience in life science research and development and has been involved in Pharmiva since its founding. He has spent the last 5 years developing Pharmiva’s first product against bacterial vaginosis, among other things. Now he runs the dermatology-focused development company Zelmic AB as CEO since 2019. He was one of the founders of Zelmic in 2002. 

Other ongoing assignments:
Zelmic AB (CEO, director), Indavvio AB (director) 

Holdings in Pharmiva AB:
503 804 shares

Independent:
Not independent in relation to the Company, independent in relation to the owners. 

Ingrid Atteryd Heiman

Ingrid Atteryd Heiman

Director since 2020

General info:
Ingrid was born in 1958 and holds a M.Sc. in Economics from Lund University, Sweden and an MBA in International Business from Uppsala University, Sweden and StyrelseAkademiens ordförandeutbildning.

Experience:
Ingrid has more than 15 years of experience in the self-care market, as CEO and Chairman of Svensk Egenvård and its European counterpart, and as CEO and Chairman of Ellen AB. Ingrid also brings experience from several listed life science companies on the Nasdaq First North Growth Market and Spotlight Stock Market

Other ongoing assignments:
Doxa AB (Chairman), Dignitana AB (director), Redwood Pharma AB (director), CarpoNovum AB (director), Parkinson Research Foundation (asset manager).

Holdings in Pharmiva AB:
2000 shares

Independent:
Ingrid is independent in relation to the Company and its management, as well as to the Company’s major shareholders.

Karin Bryder

Karin Bryder

Director since 2019

General info:
Karin was born in 1965 and holds a Ph.D. in Medical Science with focus on Immunology from Lund University. 

Experience:
Karin has more than 20 years of experience in the life science industry, which includes vaccine research at SSI in Denmark, protein drug development at Alligator Bioscience AB, drug development as CEO of ProNoxis AB, development and marketing of medical devices as co-founder of Colzyx AB and CEO of Invent Medic Sweden AB. Karin has spent the last five years building Invent Medic from a development company to a sales company of products in the women’s health segment. In 2016, Invent Medic was listed on the Spotlight Stock Market.

Other ongoing assignments:
Invent Medic AB (CEO), Colzyx AB (Chairman), bulb Intelligence AB (director), Bryder Consulting AB (Chairman), Avena Partners (Chairman) 

Holdings in Pharmiva AB:
0 shares

Independent:
Karin is independent in relation to the Company and its management, as well as to the Company’s major shareholders  

Ulf Blom

Ulf Blom

Director since 2020

General info:
Ulf was born in 1965 and holds a M.Sc. in Economics and is a certified pharmaceutical consultant with courses in strategy, leadership, governance and due diligence.

Experience:
Ulf has more than 20 years of experience from pharmaceutical companies such as Novo Nordisk, Astra Zeneca and ALK AS. He has spent the last 13 years in the biotech industry as EVP Marketing & Innovation at the Nasdaq-listed company Enzymatica at Ideon Science Park in Lund, which he also co-founded. Currently, he is a member of the Board of Enzymatica Care AB and previously held a position in listed Idogen AB. He also owns a financial company, MedZyme Invest AB. 

Other ongoing assignments
Enzymatica AB (EVP Marketing & Innovation), Enzymatica Care AB (director) 

Holdings in Pharmiva AB:
4 689 shares through companies 

Independent:
Ulf is independent in relation to the Company and its management, as well as to the Company’s major shareholders   

 

Kristina Ingvar

Kristina Ingvar

Director since 2020

General info:
Kristina was born in 1972 and holds a Bachelor of Science in Medicine from Lund University and a Certificate in Marketing from Executive Foundation Lund.

Experience:
Kristina has over 20 years of experience in Life Science. She works as Head of Quality and Registration in the management team at Bonesupport AB, a medical technology company active in orthopaedics listed on Nasdaq Stockholm.  Previous experiences include global leadership roles in quality and registration at Novo Nordisk A/S, a multinational world-leading diabetes pharmaceutical company listed on Nasdaq Copenhagen and the New York Stock Exchange. Kristina also has experience in marketing and product development. 

Other ongoing assignments: 
Tanketanken AB (CEO, director), Gamify AB (director), AB Stillingsöns Intressenter (Lay auditor) 

Holdings in Pharmiva AB:
24 000 shares 3000 options 

Independent:
Kristina is independent in relation to the Company and its management, as well as to the Company’s major shareholders  

Jenny Rydhström

Director since 2021

General info:
Jenny was born in 1973 and holds a master’s degree in Business Law from Linköping University and EFL’s Styrelseprogram 

Experience:
Jenny has more than 15 years of experience in both strategic and operational issues within the framework of e-commerce and digital operations, such as online geographic expansion, digital marketing, logistics, etc. Jenny has a strong focus on sales and contributes with experience from many different types of retail operations and business models, both B2B and B2C and D2C. 

Other ongoing assignments:
Gents AB samt dess sex koncernbolag (CEO and director), Simplr AB (director), Räckesbutiken AB (director). 

Holdings in  Pharmiva AB:
0 shares

Independent:
Jenny is independent in relation to the Company and its management, as well as to the Company’s major shareholders   

Medical advisors

Helena Kopp Kallner

Senior Physician at Danderyd Hospital, 

Associate Professor at Karolinska Institutet 

Emma Karling Widsell

Midwife at Danderyd Hospital maternity ward. Together with Carolina Tristen, she makes a podcast about involuntary childlessness, “Ivf-podden”, and has been a regular expert on the subject in TV4 Nyhetsmorgon. 

Rebecka Kaplan Sturk

Specialist in obstetrics/gynaecology, certified nutritionist, Acting Editor in Chief of Praktisk Medicinnekologi , diplomerad kostrådgivare, Tf. chefredaktör Praktisk Medicin.

Per-Göran Larsson

Associate Professor and Senior Physician

Isis Amer Wåhlin

 Founder and CEO 2Heal Medical

 Senior researcher Karolinska Institutet and RISE (Research Institute of Sweden)

Senior physician in obstetrics/gynaecology

Christina Östberg Lloyd

Specialist in obstetrics/gynaecology

Senior Vice President Reproductive Medicine & Maternal Health Ferring Pharmaceuticals 

Work for us

VACANCIES

We currently have no vacancies. 

Contact us

Pharmiva AB

Sankt Lars Väg 45B
222 70 Lund, Sweden

+46 (0)46 286 51 00

info@pharmiva.com 

For share related questions please contact:  ir@pharmiva.com

Have you experienced a side effect from our product Vernivia? Please contact us at: complaint@vernivia.com

Product website:

www.vernivia.com